These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1267821)

  • 1. Substrate-selective inhibition of monoamine oxidase by some cyclopropylamino substituted oxadiazoles.
    Long RF; Mantle TJ; Wilson K
    Biochem Pharmacol; 1976 Feb; 25(3):247-52. PubMed ID: 1267821
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the selective inhibition of membrane-bound rat liver monoamine oxidase.
    Mantle TJ; Wilson K; Long RF
    Biochem Pharmacol; 1975 Nov; 24(22):2031-8. PubMed ID: 1212252
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
    Fuller RW
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):32-7. PubMed ID: 4386711
    [No Abstract]   [Full Text] [Related]  

  • 4. Benzo-2,1,5-oxadiazoles--a novel class of heterocyclic monoamine oxidase inhibitors.
    Bolt AG; Ghosh PB
    Biochem Pharmacol; 1974 Jul; 23(14):1963-8. PubMed ID: 4422659
    [No Abstract]   [Full Text] [Related]  

  • 5. [Conjugated dinitrocompound dianions as inhibitors of the oxidative deamination of monoamines].
    Gureeva ZP; Mostiaeva LV
    Biokhimiia; 1984 Nov; 49(11):1840-6. PubMed ID: 6549266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Furoxanobenzofuroxan, a selective monoamine oxidase inhibitor.
    Bolt AG; Sleigh MJ
    Biochem Pharmacol; 1974 Jul; 23(14):1969-77. PubMed ID: 4425396
    [No Abstract]   [Full Text] [Related]  

  • 7. On the substrate-binding sites of the active centre of mitochondrial monoamine oxidase.
    Severina IS
    Eur J Biochem; 1973 Oct; 38(2):239-46. PubMed ID: 4773873
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition patterns of monoamine oxidase in sub-fractions of rat brain mitochondria in presence of some selective inhibitors.
    Mitra C; Guha SR
    Biochem Pharmacol; 1979 Apr; 28(7):1135-7. PubMed ID: 444271
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of monoamine oxidase by amphetamine and related compounds.
    Mantle TJ; Tipton KF; Garrett NJ
    Biochem Pharmacol; 1976 Sep; 25(18):2073-7. PubMed ID: 985546
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of different substrates on the inhibition of rat brain and liver monoamine oxidase by arylalkylhydrazines.
    Popov N; Matthies H; Lietz W; Thiemann C; Jassmann E
    Biochem Pharmacol; 1970 Aug; 19(8):2413-8. PubMed ID: 5520601
    [No Abstract]   [Full Text] [Related]  

  • 11. On the selective inhibition by some monoamine oxidase inhibitors of deamination of biogenic monoamines in vivo.
    Gorkin VZ; Romanova LA
    Biochem Pharmacol; 1968 Jun; 17(6):855-60. PubMed ID: 5661349
    [No Abstract]   [Full Text] [Related]  

  • 12. Selectivity of 4-methoxyphenethylamine derivatives as inhibitors of monoamine oxidase.
    Keller WJ; Ferguson GG
    J Pharm Sci; 1976 Oct; 65(10):1539-40. PubMed ID: 978418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the inhibition by harmine of oxidative deamination of biogenic monoamines.
    Gorkin VZ; Tatyanenko LV
    Life Sci; 1967 Apr; 6(8):791-5. PubMed ID: 6034186
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective inhibition of monoamine oxidase in rat brain mitochondria.
    Fuller RW; Warren BJ; Molloy BB
    Biochem Pharmacol; 1970 Nov; 19(11):2934-6. PubMed ID: 5512701
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study of antimonoamine oxidase action and pharmacological properties of 2,3-dihydro-1H-benz[d,e]isoquinoline hydrochloride].
    Gorkin VZ; Tochilkin AI; Andreeva NI; Mashkovskiĭ MD; Zhuravleva GV
    Farmakol Toksikol; 1974; 37(6):651-5. PubMed ID: 4464086
    [No Abstract]   [Full Text] [Related]  

  • 16. [Monoamine oxidase. 12. Substrate specificity of monoamine oxidase in the rabbit brain and liver].
    Nabatame E
    Nihon Yakurigaku Zasshi; 1971 Jul; 67(4):374-86. PubMed ID: 5165262
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution and inhibition characteristics of human brain monoamine oxidase.
    Owen F; Cross AJ; Lofthouse R; Glover V
    Biochem Pharmacol; 1979 Apr; 28(7):1077-80. PubMed ID: 444264
    [No Abstract]   [Full Text] [Related]  

  • 18. Nitroglycerin (glyceryl trinitrate) as a monoamine oxidase inhibitor.
    Ogawa K; Gudbjarnason S; Bing RJ
    J Pharmacol Exp Ther; 1967 Mar; 155(3):449-55. PubMed ID: 4960617
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and pharmacological effects of some alkyl-, aryl-, and aralkylsydnonimines.
    Yashunskii VG; Gorkin VZ; Mashkovskii MD; Altshuler RA; Veryovkina IV; Kholodov LE
    J Med Chem; 1971 Oct; 14(10):1013-5. PubMed ID: 5165569
    [No Abstract]   [Full Text] [Related]  

  • 20. Further studies of the monoamine oxidase inhibiting activity of formanilides and formamidines.
    Benezet HJ; Knowles CO
    Gen Pharmacol; 1980; 11(4):357-60. PubMed ID: 7399253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.